INVO Fertility (IVF) Net Income towards Common Stockholders Growth (3y) (2014 - 2025)
INVO Fertility (IVF) Net Income towards Common Stockholders Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 | -1.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.23% |
| Jun 30, 2025 | -23.56% |
| Mar 31, 2025 | -86.04% |
| Dec 31, 2024 | -242.17% |
| Sep 30, 2024 | 10.08% |
| Jun 30, 2024 | -7.30% |
| Mar 31, 2024 | 13.34% |
| Dec 31, 2023 | 19.39% |
| Sep 30, 2023 | 11.02% |
| Jun 30, 2023 | -19.20% |
| Mar 31, 2023 | -20.87% |
| Dec 31, 2022 | -54.03% |
| Sep 30, 2022 | -53.11% |
| Jun 30, 2022 | -126.36% |
| Mar 31, 2022 | -80.62% |
| Dec 31, 2021 | 28.70% |
| Sep 30, 2021 | -96.66% |
| Jun 30, 2021 | 0.86% |
| Mar 31, 2021 | -156.89% |
| Dec 31, 2020 | -166.38% |